UrologyNCT07644819
Preoperative Outreach to Improve Surgical Attendance
A study testing Preoperative Outreach in people with Urology, run by University of California, San Francisco at 1 site in United States.
Trial summary
This study aims to evaluate the impact of reminder call intervention on no-shows for urologic procedures in patients identified to be high risk for no-showing. Patients scheduled to undergo a urologic procedure will be randomized into two groups: the intervention group, who receives a series of reminder calls and text… Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Urology
- What is being tested?
- Preoperative Outreach
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 68 participants
- Where
- 1 siteUnited States
- Study dates
- Nov 2026to May 2027
- Phase
- Interventional
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Adults aged 18 years or older
- Identified as high risk for no-show by the study predictive model
- Scheduled to undergo a urologic procedure at UCSF/UCSF affiliated sites
Who cannot join
- Younger than 18 years of age
- Not scheduled for a urologic procedure
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
Darren Chau contact
United States1 site
University of California, San Francisco
San Francisco, California, 94143
About this study
Official title: Reducing No-Shows in High-Risk Urology Patients Through Enhanced Preoperative Outreach
This study aims to evaluate the impact of reminder call intervention on no-shows for urologic procedures in patients identified to be high risk for no-showing. Patients scheduled to undergo a urologic procedure will be randomized into two groups: the intervention group, who receives a series of reminder calls and text messages about appointment details and patient questions prior to the procedure date; and the control group, who receives standard care only. Secondary outcomes include rates of patient re-scheduling and healthcare utilization.
- Conditions
- Urology
- Being tested
- Preoperative Outreach
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Preoperative OutreachBehavioural
Participants will receive enhanced preoperative outreach consisting of reminder phone calls 7 days, 3 days, 1 day, and on the day of their scheduled urologic procedure, in addition to standard care. Calls will review appointment details, address patient questions, assess barriers to attendance, provide text-based communication access, and facilitate referral to social work when appropriate.
| Study group | Role | What they receive |
|---|---|---|
| Enhanced Preoperative Outreach | Experimental | Participants receive standard care plus reminder phone calls at 7 days, 3 days, 1 day, and the day of the procedure, text messaging access, assessment of barriers to attendance, and referral to social work when appropriate. Receives: Behavioral: Preoperative Outreach |
| Standard Care | No intervention | Participants receive standard preoperative care, including procedure scheduling, preoperative anesthesia evaluation, and routine surgery center reminder calls. |
What is being measured
The primary outcome is the main question the study is designed to answer.
Procedure No-Show Rate
Whether the participant attended their scheduled urologic procedure
Measured: From enrollment until the scheduled procedure date (up to 8 weeks)
Secondary outcomes (1)
Procedure Rescheduling Rate
Whether the participant rescheduled their procedure
Measured: From enrollment until the scheduled procedure date (up to 8 weeks)
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted12 Jun 2026
- Study startNov 2026 (estimated)
- Primary completionMay 2027 (estimated)
- Study completionMay 2027 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (6)Papers the sponsor has linked to this study.
- Other trials for UrologyStudies of the same condition, open and under way.
- More trials run by University of California, San FranciscoThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Health services research
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Enrolment
- 68 participants (estimated)
Sponsor and investigators
- Lead sponsor
- University of California, San Francisco
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
- Investigators
- David Bayne, MD, Principal investigator, University of California, San Francisco
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07644819
- Sponsor's protocol ID
- 26-46897
- Status last verified
- Oct 2026
- First submitted
- 8 Jun 2026
- Last updated
- 13 Oct 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Publications
Wongtangman K, Azimaraghi O, Freda J, Ganz-Lord F, Shamamian P, Bastien A, Mirhaji P, Himes CP, Rupp S, Green-Lorenzen S, Smith RV, Medrano EM, Anand P, Rego S, Velji S, Eikermann M. Incidence and predictors of case cancellation within 24 h in patients scheduled for elective surgical procedures. J Clin Anesth. 2022 Dec;83:110987. doi: 10.1016/j.jclinane.2022.110987. Epub 2022 Oct 26.
PubMed 36308990Weaver KR, Talley M, Mullins M, Selleck C. Evaluating Patient Navigation to Improve First Appointment No-show Rates in Uninsured Patients with Diabetes. J Community Health Nurs. 2019 Jan-Mar;36(1):11-18. doi: 10.1080/07370016.2018.1555315.
PubMed 30793960Suarez PA, Srirangapatanam S, Leng L, Momodu MM, Neuhaus J, Bayne DB. Enhancing surgical efficiency: predicting same-day cancellations in urologic procedures. World J Urol. 2025 Dec 17;44(1):48. doi: 10.1007/s00345-025-06155-6.
PubMed 41405624Sommer JL, Jacobsohn E, El-Gabalawy R. Impacts of elective surgical cancellations and postponements in Canada. Can J Anaesth. 2021 Mar;68(3):315-323. doi: 10.1007/s12630-020-01824-z. Epub 2020 Oct 21.
PubMed 33085061Lee CM, Rodgers C, Oh AK, Muckler VC. Reducing Surgery Cancellations at a Pediatric Ambulatory Surgery Center. AORN J. 2017 Apr;105(4):384-391. doi: 10.1016/j.aorn.2017.01.011.
PubMed 28336027Kaddoum R, Fadlallah R, Hitti E, El-Jardali F, El Eid G. Causes of cancellations on the day of surgery at a Tertiary Teaching Hospital. BMC Health Serv Res. 2016 Jul 13;16:259. doi: 10.1186/s12913-016-1475-6.
PubMed 27412041